Vincent P. Ippolito, EVP & Chief Commercial Officer at Anacor Pharmaceuticals, Inc. (ANAC), sold 9,000 shares at $44.34 ($395K) on 2015-03-03, disclosed to the SEC on 2015-03-04.
Scheduled sale ($395k) by EVP & Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.81 | 7,846 | $344K | 87.0% |
| 2 | $44.34 | 1,154 | $51K | 13.0% |
| Total | $43.88 avg | 9,000 | $395K | 100% |
| Filing → |
| ANAC | SELL | 2016-01-05 | $181K | — | Filing → |
| ANAC | SELL | 2015-12-11 | $2.2M | — | Filing → |
| MRX | SELL | 2011-05-17 | $4.2M | — | Filing → |